Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lucid Diagnostics (LUCD) Change in Receivables (2022 - 2025)

Historic Change in Receivables for Lucid Diagnostics (LUCD) over the last 4 years, with Q3 2025 value amounting to $177000.0.

  • Lucid Diagnostics' Change in Receivables rose 24508.2% to $177000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $383000.0, marking a year-over-year increase of 215294.12%. This contributed to the annual value of $28000.0 for FY2023, which is 11530.05% up from last year.
  • Per Lucid Diagnostics' latest filing, its Change in Receivables stood at $177000.0 for Q3 2025, which was up 24508.2% from $312000.0 recorded in Q2 2025.
  • Lucid Diagnostics' Change in Receivables' 5-year high stood at $312000.0 during Q2 2025, with a 5-year trough of -$122000.0 in Q3 2024.
  • Over the past 4 years, Lucid Diagnostics' median Change in Receivables value was $9000.0 (recorded in 2023), while the average stood at $24500.0.
  • Over the last 5 years, Lucid Diagnostics' Change in Receivables had its largest YoY gain of 128750.0% in 2024, and its largest YoY loss of 77142.86% in 2024.
  • Over the past 4 years, Lucid Diagnostics' Change in Receivables (Quarter) stood at -$14000.0 in 2022, then soared by 271.43% to $24000.0 in 2023, then crashed by 608.33% to -$122000.0 in 2024, then soared by 245.08% to $177000.0 in 2025.
  • Its Change in Receivables stands at $177000.0 for Q3 2025, versus $312000.0 for Q2 2025 and $16000.0 for Q1 2025.